Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?

Détails

Ressource 1Télécharger: Selection of data sets for FAIRification in drug discovery and development.pdf (384.00 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_7C02573AB3FE
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?
Périodique
Drug discovery today
Auteur⸱e⸱s
Alharbi E., Gadiya Y. (co-premier), Henderson D., Zaliani A., Delfin-Rossaro A., Cambon-Thomsen A., Kohler M., Witt G., Welter D., Juty N., Jay C., Engkvist O., Goble C., Reilly D.S., Satagopam V., Ioannidis V., Gu W., Gribbon P.
ISSN
1878-5832 (Electronic)
ISSN-L
1359-6446
Statut éditorial
Publié
Date de publication
08/2022
Peer-reviewed
Oui
Volume
27
Numéro
8
Pages
2080-2085
Langue
anglais
Notes
Publication types: Journal Article ; Review ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
Despite the intuitive value of adopting the Findable, Accessible, Interoperable, and Reusable (FAIR) principles in both academic and industrial sectors, challenges exist in resourcing, balancing long- versus short-term priorities, and achieving technical implementation. This situation is exacerbated by the unclear mechanisms by which costs and benefits can be assessed when decisions on FAIR are made. Scientific and research and development (R&D) leadership need reliable evidence of the potential benefits and information on effective implementation mechanisms and remediating strategies. In this article, we describe procedures for cost-benefit evaluation, and identify best-practice approaches to support the decision-making process involved in FAIR implementation.
Mots-clé
Cost-Benefit Analysis, Drug Discovery, Cost–benefit, Drug discovery, FAIR, FAIRification, Pharmaceutical R&D
Pubmed
Web of science
Open Access
Oui
Création de la notice
31/05/2022 13:20
Dernière modification de la notice
11/06/2024 7:13
Données d'usage